346 related articles for article (PubMed ID: 24474430)
1. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.
Rhodes NJ; Liu J; McLaughlin MM; Qi C; Scheetz MH
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):165-71. PubMed ID: 25801780
[TBL] [Abstract][Full Text] [Related]
3. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
4. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
[TBL] [Abstract][Full Text] [Related]
5. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
[TBL] [Abstract][Full Text] [Related]
6. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
[TBL] [Abstract][Full Text] [Related]
7. Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.
Rhodes NJ; Kuti JL; Nicolau DP; Van Wart S; Nicasio AM; Liu J; Lee BJ; Neely MN; Scheetz MH
Antimicrob Agents Chemother; 2015 Dec; 60(3):1401-10. PubMed ID: 26666929
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
9. Cefepime effectiveness in Gram-negative bloodstream infections.
Al-Hasan MN; Eckel-Passow JE; Baddour LM
J Antimicrob Chemother; 2011 May; 66(5):1156-60. PubMed ID: 21393128
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection.
Wang W; Jiang T; Zhang W; Li C; Chen J; Xiang D; Cao K; Qi LW; Li P; Zhu W; Chen W; Chen Y
Am J Infect Control; 2017 Jan; 45(1):59-64. PubMed ID: 27765296
[TBL] [Abstract][Full Text] [Related]
11. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
[TBL] [Abstract][Full Text] [Related]
15. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and risk factors for fatality in patients with bloodstream infections caused by glucose non-fermenting gram-negative Bacilli.
Chang TY; Lee CH; Liu JW
J Microbiol Immunol Infect; 2010 Jun; 43(3):233-9. PubMed ID: 21291852
[TBL] [Abstract][Full Text] [Related]
18. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
[No Abstract] [Full Text] [Related]
19. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
[TBL] [Abstract][Full Text] [Related]
20. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
